Latest Biotech News

KRAS drug developers are advancing to the next generation of targeted therapies for lung cancer, according to early-cut data highlighted in a new report from San Diego. The coverage points to...

UCB announced plans to buy Neurona Therapeutics in a deal valued at $650 million, with up to $500 million in milestone payments, to broaden its clinical-stage epilepsy portfolio. The transaction...

Revolution Medicines reported standout Phase III data for its once-daily oral daraxonrasib in metastatic pancreatic ductal adenocarcinoma, with investors reacting strongly to the early readout. In...

Obsidian Therapeutics moved to combine with Galera Therapeutics in a merger that brings $350 million in funding earmarked for cancer drug trials. The transaction is positioned around Obsidian’s...

Odyssey Therapeutics is preparing a second attempt at an initial public offering after withdrawing its first try a year earlier. The Boston-based company filed for the IPO again, aiming to take...

10x Genomics unveiled its Atera spatial platform at AACR 2026, positioning the instrument for whole-transcriptome spatial biology at scale. Company leadership said Atera addresses measurement...

New reporting describes how automation and AI are changing organoid research workflows, enabling teams to move beyond traditional 2D cell culture and animal models. The article frames organoids as...

The Breakthrough Prize Foundation honored gene therapy pioneers with the 2026 Breakthrough Prize for Life Sciences, spotlighting teams behind landmark advances that helped establish clinical gene...

A preclinical study reported a bacterial-vaccine approach to boosting colorectal cancer therapy in mice by combining immune checkpoint inhibitors with an oral bread-based formulation. The report...

Researchers reported that wastewater-based epidemiology can detect the emergence of clinically significant, drug-resistant Candida auris strains within healthcare settings. The work, described as...

Revolution Medicines said its once-daily oral daraxonrasib produced a statistically and clinically meaningful overall survival benefit in its Phase III RASolute 302 trial in metastatic pancreatic...

Obsidian Therapeutics announced a merger with Galera Therapeutics that includes a $350 million infusion aimed at advancing its tumor-infiltrating lymphocyte (TIL) pipeline. The deal would bring...

10x Genomics unveiled its Atera spatial platform at AACR 2026, pitching whole-transcriptome spatial biology at higher throughput and plex than its prior Xenium system. The company said Atera...

Researchers reported that adenine base editing (ABE) can rescue a cryptic splice mutation tied to cardiac-type Fabry disease in cells. The work, published in Gene Therapy, targets a specific G>A...

STAT+ highlighted how the search for durable KRAS-mutant therapies has accelerated since early KRAS drugs fell short on response durability. The report centers on Revolution Medicines’...

A Nature Communications study reported that wastewater-based epidemiology can detect the emergence of clinically significant, drug-resistant Candida auris in healthcare settings. Researchers used...

Grey Wolf Therapeutics appointed serial entrepreneur Edwin Moses as chair, while Harbour BioMed (HBM Holdings) hired Adam Zong as president. Moses’ background includes leadership roles across UK...

A BIOCENTURY report said the FDA’s budget proposal includes a policy wish list that would make pediatric priority review vouchers permanent and would reduce industry participation on advisory...

CSPI criticized the FDA’s plans to convene a Pharmacy Compounding Advisory Committee meeting in July to consider adding seven injectable peptides to what can be compounded. The statement argues...

The NSF awarded a record 2,599 Graduate Research Fellowships after previously cutting the number to 1,000 the year before. The rebound, announced after concerns that application timing and...